Hormonal birth control may be associated with an increased risk of depression in certain individuals, but it does not cause depression for most users. Confidence in this assessment is moderate due to the mixed...
Why this question matters
Evidence on hormonal birth control and depression is mixed: many users report no mood changes or improved wellbeing, while some studies find higher rates of depression diagnoses or antidepressant use in certain groups. The strongest concern appears to involve adolescents, people with prior mood symptoms, and some progestin-only or long-acting methods, but causation is difficult to establish.
The claim being judged
The claim asks whether hormonal birth control causes depression. Hormonal birth control includes combined estrogen-progestin pills, progestin-only pills, implants, injections, hormonal intrauterine devices, vaginal rings, and patches.
This question matters because depression is common, hormonal contraception is widely used, and decisions about contraception often involve balancing pregnancy prevention, menstrual symptom control, acne, endometriosis, polycystic ovary syndrome symptoms, and personal preferences.
A careful judgment needs to distinguish several related ideas: whether mood changes can occur in some users, whether population-level studies show increased depression-related outcomes, whether those associations reflect a direct biological effect, and whether the overall risk-benefit balance changes for specific groups.
What the evidence shows
Randomized trials and observational studies do not give a single simple answer. Some randomized evidence finds little average worsening of depressive symptoms among users of combined hormonal contraception, while observational studies in large health registries have reported associations between hormonal contraception and later antidepressant use or depression diagnoses.
The observational signal has often been stronger among adolescents and first-time users. Some studies also report differences by formulation or delivery method, including progestin-only methods, implants, injections, and hormonal IUDs, though comparisons across studies are difficult because users differ in age, health history, reasons for choosing a method, and access to care.
A key limitation is confounding: people who choose, stop, or switch contraceptive methods may differ in ways that also affect depression risk. Factors such as relationship status, menstrual symptoms, postpartum status, prior mental health history, socioeconomic stress, and healthcare-seeking behavior can influence both contraceptive use and depression-related outcomes.
Clinically, many guidelines do not treat depression as a general contraindication to hormonal contraception. At the same time, they recognize that individual mood side effects can matter and that shared decision-making, follow-up, and method switching may be appropriate when symptoms appear after starting a method.
Where uncertainty remains
The main uncertainty is the size of any causal effect for particular people and particular contraceptive formulations. Average effects in trials can miss smaller vulnerable subgroups, while registry associations can overstate or understate causal effects because of unmeasured differences between users and non-users.
More evidence is needed on people with prior depression, adolescents, postpartum users, and those using newer or less-studied formulations. Studies that track mood before and after starting contraception, compare similar users across methods, and include patient-reported mood outcomes would be especially helpful.
For an individual user, timing can be informative but is not definitive. New or worsening depressive symptoms after starting a method should be discussed with a clinician, especially if symptoms are severe, persistent, or include thoughts of self-harm.
The three parts of the claim
The umbrella claim is actually several claims bundled into one. Each needs its own evaluation.
Model comparison
How each panel model rated the three parts of the claim| Model | Part 1 | Part 2 | Part 3 | Overall |
|---|---|---|---|---|
| OpenAI GPT-5.4 | Yes · 78% | No · 72% | Mixed · 64% | No · 65% |
| Grok 4.3 | Yes · 78% | No · 72% | Mixed · 64% | Mixed · 70% |
| Llama 4 Maverick | Yes · 78% | No · 72% | Mixed · 64% | Mixed · 70% |
| Mistral Medium 3.5 | Yes · 78% | No · 72% | Mixed · 64% | Mixed · 70% |
| Claude Opus 4.7 | Yes · 78% | No · 72% | Mixed · 64% | Mixed · 65% |
| Gemini 3.1 Pro | Yes · 78% | No · 72% | Mixed · 64% | Mixed · 70% |
| DeepSeek V4 Pro | Yes · 78% | No · 72% | Mixed · 64% | No · 70% |
| GLM 5.1 | Yes · 78% | No · 72% | Mixed · 64% | No · 75% |
| Qwen 3.7 Max | Yes · 78% | No · 72% | Mixed · 64% | Mixed · 85% |
| Kimi K2.6 | — | — | — | Incomplete |
What would change our mind
The current evidence leans one way. But we're not committed to the conclusion, we're committed to the evidence.
- Large randomized trials comparing specific hormonal methods with non-hormonal methods that measure depressive symptoms before and after initiation.
- High-quality studies focused on adolescents, first-time users, and people with prior depression, with strong control for baseline mental health and social factors.
- Consistent evidence that one formulation, dose, or delivery method has a clearly different depression-related risk profile.
- Updated clinical guidelines that change recommendations for people with current or past depressive disorders.
- Mechanistic studies linking specific hormonal exposures to mood changes in ways that align with clinical outcome data.
Common questions
References
Peer Reviewed Study
Clinical Guideline
Systematic Review
Medical Organization
Pharmacovigilance
What each model said
Hormonal birth control does not cause depression for most users, though some observational studies report modest associations with higher rates of depression diagnoses or antidepressant prescriptions, especiall...
The claim is only partly supported: hormonal birth control does not clearly cause depression for most users, but it may increase depression-related risk in some people, and the risk appears to vary by age, prior vulnerability, and method. Confidence: moderate. Key evidence: - Large observational studies, including a widely cited Danish cohort study in JAMA Psychiatry, found that hormonal contraceptive users had higher rates of first antidepressant use and depression diagnosis than nonusers, with the strongest assoc...
The claim that hormonal birth control *causes* depression is not definitively supported by current evidence. While some observational studies (e.g., JAMA Psychiatry 2016) show associations between hormonal cont...
Hormonal birth control does not appear to cause depression in most users, but it is associated with increased depression-related outcomes in specific subgroups, and a causal relationship cannot be confidently e...
Current evidence does not support the claim that hormonal birth control causes depression for most users, though there is a well-documented association between hormonal contraceptive use and depression-related...
Hormonal birth control does not cause depression for most users, but it is associated with an increased risk of depression-related outcomes in certain populations, such as adolescents and individuals with a pri...
Hormonal birth control does not cause depression for most users, but it is associated with a small increased risk of depression diagnoses or antidepressant use in certain subgroups—most notably adolescents, ind...
Hormonal birth control has not been shown to cause depression in most users, and a universal causal relationship is not established. However, observational studies indicate a small but statistically significant...
Hormonal birth control does not cause depression for most users, but it is associated with an increased risk of depression-related outcomes in specific subgroups, and a definitive, universal causal link remains...